I. Kathmann
AuthID: R-006-W8H
1
TÃTULO: The EGFR TK inhibitor gefitinib (iressa), but not erlotinib (tarceva), is a substrate for BCRP: Impact of cellular folate status on biological activity
AUTORES: Lemos, C; Kathmann, I; Hoebe, EK; Jansen, G; Peters, GJ;
PUBLICAÇÃO: 2006, FONTE: 4th International Symposium on Targeted Anticancer Therapies in ANNALS OF ONCOLOGY, VOLUME: 17
AUTORES: Lemos, C; Kathmann, I; Hoebe, EK; Jansen, G; Peters, GJ;
PUBLICAÇÃO: 2006, FONTE: 4th International Symposium on Targeted Anticancer Therapies in ANNALS OF ONCOLOGY, VOLUME: 17
INDEXADO EM: 
WOS
WOS